Medical/Pharmaceuticals

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...

2022-04-06 19:37 2317

Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors

HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...

2022-04-06 17:10 2164

Harbour BioMed Announces Poster Presentation on the Novel Bispecific Antibody PD-L1xCD40 at Upcoming American Association for Cancer Research (AACR) Annual Meeting

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, today announced that the poster presenta...

2022-04-06 15:04 2221

PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022

MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the listing of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) (PSMA-PET) imaging for patients with prostate cancer on the Medicare Benefits Sche...

2022-04-06 12:47 2251

Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy

SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2022-04-06 12:43 2872

Kintor Pharma's Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study

* Proxalutamide demonstrates a significant reduction in hospitalization/death rate with a protection rate reaching 100% for patients treated more than seven days (p <0.02). * Proxalutamide reduced risk of hospitalization or death especially in those with high-risk factors. * Proxalutamid...

2022-04-06 09:22 1395

VISTA Eye Specialist (VISTA) introduces cutting-edge Swiss Technology for Cataract Surgery, giving patients a simple, fast and safe procedure.

PETALING JAYA, Malaysia, April 6, 2022 /PRNewswire/ -- VISTA is always looking to provide the latest technology availablefor Cataract patients - making the surgery simpler and improve the result, safety and comfort - not just for the patient but also the surgeon. Having Robotic Computer-aided tec...

2022-04-06 09:11 2396

Cambridge Nutranostics has developed a point-of-care prototype of OCCL test for testing blood plasma oxygen to monitor health in post stroke and TIA patients for dementia prevention

CAMBRIDGE, England, April 6, 2022 /PRNewswire/ -- Cambridge Nutranostics Ltd, CNL,http://occltest.com   has begun validation in clinic of its first test prototype to assess and monitor plasma oxygen, the part of the total blood O2, which can cross the capillary wall and deli...

2022-04-06 09:00 1370

Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals

Discovery-based pharmaceutical company in Japan leverages Cloudera for greater speed to insights across its research, development, and post-market value chain. SINGAPORE, April 6, 2022 /PRNewswire/ -- Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company,Sh...

2022-04-06 08:00 2420

Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis

SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today t...

2022-04-06 08:00 1995

Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals

SAN DIEGO and TOKYO, April 5, 2022 /PRNewswire/ -- Singlera Genomics Inc. today announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to better understand biological reactions to pharmaceuticals using Singlera's mTitan platform. mTitan allows for the int...

2022-04-05 21:56 1574

Nihon Medi-Physics Attains World's First Manufacturing of Actinium-225 with Cyclotron on Production Scale for Investigational Drugs

- Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel Treatment for Cancer - TOKYO, April 5, 2022 /PRNewswire/ -- Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company inJapan, announced on April 5, 2022, that the company has successfully manufactured act...

2022-04-05 16:00 1564

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK

LONDON, April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement withSciensus Rare

2022-04-05 14:00 2106

Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions

SINGAPORE, April 5, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients...

2022-04-05 13:30 2646

TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy

Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNew...

2022-04-05 13:00 2245

Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols

JAKARTA, April 5, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-05 09:00 3124

Formus Labs Adds Seasoned Medical Technology Executives Lloyd McCann and Meraj Khan to Board of Directors

Formus combines AI and biomechanics in fully automated preoperative planning workflows that empower orthopedic surgeons to optimize patient outcomes AUCKLAND, New Zealand, April 5, 2022 /PRNewswire/ --  Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement sur...

2022-04-05 03:00 1954

Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers

JAKARTA, April 4, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-04 23:35 1852

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today dose administration for the first subject in a U.S. Phase I clinical tr...

2022-04-04 21:31 2637

Vieworks to Make Its Debut at AACR Annual Meeting 2022 with VISQUE InVivo Series

ANYANG, South Korea, April 4, 2022 /PRNewswire/ -- Vieworks will be showcasing its optical in vivo imaging systems at AACR Annual Meeting (April 10-13, booth 2308). VISQUE InVivo Art is Vieworks' premium preclinical optical imaging system for high-sensitivity fluorescent & bioluminescent imaging ...

2022-04-04 21:00 1765
1 ... 251252253254255256257 ... 573